Skip to main content
SpringerLink
Log in

Recent changes in taxonomy and disease manifestations of the rapidly growing mycobacteria

  • Current Topic: Review
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

Rapidly growing mycobacteria are a complex group of environmental organisms that cause human disease. Eight taxonomic groups of pathogens are recognized of which three, theMycobacterium chelonae-like organism (MCLO) and the twoMycobacterium fortuitum third biovariant groups, have yet to receive names pending DNA-DNA homology studies. Clinical disease due to all eight taxons usually consists of skin or soft tissue infections following trauma. Nosocomial disease has become increasingly important, pseudoepidemics associated with contaminated automated endoscopic washing machines being the most recently described manifestation. The development of DNA fingerprinting technology, especially pulsed-field gel electrophoresis, has improved the possibilities of studying the epidemiology of these infections. Pulmonary disease, primarily due toMycobacterium abscessus, and disseminated cutaneous disease due toMycobacterium chelonae, have recently been characterized. Imipenem and the newer macrolide clarithromycin represent important new therapeutic agents active against these species. Other important therapeutic agents include amikacin and the newer quinolones, which have variable degrees of susceptibility within different taxonomic groups, necessitating susceptibility testing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kusunoki S, Ezaki T Proposal ofMycobacterium peregrinum sp. nov., nom. rev., and elevation ofMycobacterium chelonae subsp.abscessus (Kubica et al.) to species status:Mycobacterium abscessus comb. nov. International Journal of Systematic Bacteriology 1992, 42: 240–245.

    PubMed  Google Scholar 

  2. Lévy-Frébault V, Grimont F, Grimont PAD, David HL Deoxyribonucleic acid relatedness study of theMycobacterium fortuitum-Mycobacterium chelonae complex. International Journal of Systematic Bacteriology 1986, 36: 458–460.

    Google Scholar 

  3. Kirschner P, Kiekenbeck M, Meissner D, Wolters J, Böttger EC Genetic heterogeneity withinMycobacterium fortuitum complex species: genotypic criteria for identification. Journal of Clinical Microbiology 1992, 30: 2772–2775.

    Google Scholar 

  4. Rogall T, Wolters J, Flohr T, Böttger EC Towards a phylogeny and definition of species at the molecular level within the genusMycobacterium. International Journal of Systematic Bacteriology 1990, 40: 323–330.

    PubMed  Google Scholar 

  5. Wallace RJ, Silcox VA, Tsukamura M, Brown BA, Kilburn JO, Butler WR, Onyi G Clinical significance, biochemical features, and susceptibility patterns of sporadic isolates of theMycobacterium chelonae-like organism. Journal of Clinical Microbiology 1993, 31: 3231–3239.

    PubMed  Google Scholar 

  6. Wallace RJ, Brown BA, Silcox VA, Tsukamura M, Nash DR, Steele LC, Steingrube VA, Smith J, Sumter G, Zhang Y, Blacklock Z Clinical disease, drug susceptibility, and biochemical patterns of the unnamed third biovariant complex ofMycobacterium fortuitum. Journal of Infectious Diseases 1991, 163: 598–603.

    PubMed  Google Scholar 

  7. Silcox VA, Good RC, Floyd MM Identification of clinically significantMycobacterium fortuitum complex isolates. Journal of Clinical Microbiology 1981, 14: 686–691.

    PubMed  Google Scholar 

  8. Wallace RJ, Swenson JM, Silcox VA, Good RC, Tschen JA, Seabury Stone M Spectrum of disease due to rapidly growing mycobacteria. Reviews of Infectious Diseases 1983, 5: 657–679.

    PubMed  Google Scholar 

  9. Wallace RJ, Nash DR, Tsukamura M, Blacklock ZM, Silcox VA Human disease due toMycobacterium smegmatis. Journal of Infectious Diseases 1988, 158: 52–59.

    PubMed  Google Scholar 

  10. Band JD, Ward JI, Fraser W, Peterson NJ, Silcox VA, Good RC, Ostroy PR, Kennedy J Peritonitis due to aMycobacterium chelonae-like organism associated with intermittent chronic peritoneal dialysis. Journal of Infectious Diseases 1982, 145: 9–17.

    PubMed  Google Scholar 

  11. Wallace RJ, Brown BA, Onyi GO Skin, soft tissue, and bone infections due toMycobacterium chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. Journal of Infectious Diseases 1992, 166: 405–412.

    PubMed  Google Scholar 

  12. Brown BA, Wallace RJ, Onyi GO, De Rosas V, Wallace RJ III Activities of four macrolides, including clarithromycin, againstMycobacterium fortuitum, Mycobacterium chelonae, andM. chelonae-like organisms. Antimicrobial Agents and Chemotherapy 1992, 36: 180–184.

    PubMed  Google Scholar 

  13. Owen M, Smith A, Coultras J Granulomatous lesions occurring at site of injections of vaccines and antibiotics. Southern Medical Journal 1963, 56: 949–952.

    PubMed  Google Scholar 

  14. Hoffman PC, Fraser DW, Robiesek F, O'Bar PR, Mauney CU Two outbreaks of sternal wound infections due to organisms of theMycobacterium fortuitum complex. Journal of Infectious Diseases 1981, 143: 533–542.

    PubMed  Google Scholar 

  15. Kuritsky JN, Bullen MG, Broome CV, Silcox VA, Good RC, Wallace RJ Sternal wound infections and endocarditis due to organisms of theMycobacterium fortuitum complex. Annals of Internal Medicine 1983, 98: 938–939.

    PubMed  Google Scholar 

  16. Wallace RJ, Musser JM, Hull SI, Silcox VA, Steele LC, Forrester GD, Labidi A, Selander RK Diversity and sources of rapidly growing mycobacteria associated with infections following cardiac surgery. Journal of Infectious Diseases 1989, 159: 708–716.

    PubMed  Google Scholar 

  17. Safranek TJ, Jarvis WR, Carson LA, Cusick LB, Bland LA, Swenson JM, Silcox VA Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution. New England Journal of Medicine 1987, 317: 197–201.

    PubMed  Google Scholar 

  18. Clegg HW, Foster MT, Sanders WE, Baine WB Infection due to organisms of theMycobacterium fortuitum complex after augmentation mammaplasty: clinical and epidemiologic features. Journal of Infectious Diseases 1983, 147: 427–433.

    PubMed  Google Scholar 

  19. Wallace RJ, Steele LC, Labidi A, Silcox VA Heterogeneity among isolates of rapidly growing mycobacteria responsible for infections following augmentation mammaplasty despite case clustering in Texas and other southern coastal states. Journal of Infectious Diseases 1989, 160: 281–288.

    PubMed  Google Scholar 

  20. Fraser VJ, Jones M, Murray PR, Medoff G, Zhang Y, Wallace RJ Contaminatoin of flexible fiberoptic bronchoscopes withMycobacterium chelonae linked to an automated bronchoscope disinfection machine. American Review of Respiratory Disease 1992, 145: 853–855.

    PubMed  Google Scholar 

  21. Gubler JGH, Salfinger M, von Graevenitz A Pseudoepidemic of nontuberculous mycobacteria due to a contaminated bronchoscope cleaning machine: report of an outbreak and review of the literature. Chest 1992, 101: 1245–1249.

    PubMed  Google Scholar 

  22. Nye K, Chadha DK, Hodgkin P, Bradley C, Hancox J, Wise R Mycobacterium chelonae isolation from broncho-alveolar lavage fluid and its practical implications. Journal of Hospital Infection 1990, 16: 257–261.

    Article  PubMed  Google Scholar 

  23. Wallace RJ, Zhang Y, Brown BA, Fraser V, Mazurek GH, Maloney S DNA large restriction fragment patterns of sporadic and epidemic nosocomial strains ofMycobacterium chelonae andMycobacterium abscessus. Journal of Clinical Microbiology 1993, 31: 2697–2701.

    PubMed  Google Scholar 

  24. Pappas SA, Schaaff DM, DiCostanzo MB, King FW, Sharp JT Contamination of flexible fiberoptic bronchoscopes. American Review of Respiratory Disease 1983, 108: 391–392.

    Google Scholar 

  25. Yew W, Wong P, Woo H, Yip C, Chan C, Cheng F Characterization ofMycobacterium fortuitum isolates from sternotomy wounds by antimicrobioal susceptibilities, plasmid profiles, and ribosomal ribonucleic acid gene restriction patterns. Diagnostic Microbiology and Infectious Diseases 1993, 17: 111–117.

    Article  Google Scholar 

  26. Burns DN, Wallace RJ, Schultz ME, Zhang Y, Zubairi SQ, Pang Y, Gibert CL, Brown BA, Noel ES, Gordin FM Nosocomial outbreak of respiratory tract colonization withMycobacterium fortuitum: Demonstration of the usefulness of pulsed-field gel electrophoresis in an epidemiologic investigation. American Review of Respiratory Disease 1991, 144: 1153–1159.

    PubMed  Google Scholar 

  27. Hector JSR, Pang Y, Mazurek GH, Zhang Y, Brown BA, Wallace RJ Large restriction fragment patterns of genomicMycobacterium fortuitum DNA as strainspecific markers and their use in epidemiologic investigation of four nosocomial outbreaks. Journal of Clinical Microbiology 1992, 30: 1250–1255.

    PubMed  Google Scholar 

  28. Griffith DE, Girard WM, Wallace RJ Clinical features of pulmonary disease caused by rapidly growing mycobacteria: an analysis of 154 patients. American Review of Respiratory Disease 1993, 147: 1271–1278.

    PubMed  Google Scholar 

  29. Ingram CW, Tanner DC, Durack DT, Kernodle GW, Corey GR Disseminated infection with rapidly growing mycobacteria. Clinical Infectious Diseases 1993, 16: 463–471.

    PubMed  Google Scholar 

  30. Wallace RJ, Tanner D, Brennan PJ, Brown BA Clinical trial of clarithromycin for cutaneous (disseminated) infection due toMycobacterium chelonae. Annals of Internal Medicine 1993, 119: 482–486.

    PubMed  Google Scholar 

  31. Wallace RJ, Swenson JM, Silcox VA, Bullen MG Treatment of nonpulmonary infections due toMycobacterium fortuitum andMycobacterium chelonae on the basis of in vitro susceptibilities. Journal of Infectious Diseases 1985, 152: 500–514.

    PubMed  Google Scholar 

  32. Yew WW, Kwan SYL, Ma WK, Aung-khin M, Mok CK Combination of ofloxacin and amikacin in the treatment of sternotomy wound infection. Chest 1989, 95: 1051–1055.

    PubMed  Google Scholar 

  33. Swenson JM, Thornsberry C, Silcox VA Rapidly growing mycobacteria: testing of susceptibility to antimicrobial agents by broth microdilution. Antimicrobial Agents and Chemotherapy 1982, 22: 186–192.

    PubMed  Google Scholar 

  34. Swenson JM, Wallace RJ, Silcox VA, Thornsberry C Antimicrobial susceptibility of five subgroups ofMycobacterium fortuitum andMycobacterium chelonae. Antimicrobial Agents and Chemotherapy 1985, 28: 807–811.

    PubMed  Google Scholar 

  35. Wallace RJ, Brown BA, Onyi GO Susceptibilities ofMycobacterium fortuitum biovar.fortuitum and the two subgroups ofMycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid. Antimicrobial Agents and Chemotherapy 1991, 35: 773–775.

    PubMed  Google Scholar 

  36. Van Caekenberghe D Comparative in vitro activities of ten fluoroquinolones and fusidic acid againstMycobacterium spp. Journal of Antimicrobial Chemotherapy 1990, 26: 381–386.

    PubMed  Google Scholar 

  37. Wallace RJ, Bedsole G, Sumter G, Sanders CV, Steele LC, Brown BA, Smith J, Graham DR Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy. Antimicrobial Agents and Chemotherapy 1990, 34: 65–70.

    PubMed  Google Scholar 

  38. Yew WW, Kwan SYL, Wong PC, Lee J Ofloxacin and imipenem in the treatment ofMycobacterium fortuitum andMycobacterium chelonae lung infections. Tubercle 1990, 71: 131–133.

    Article  PubMed  Google Scholar 

  39. Watt B, Edwards JR, Rayner A, Grindey AJ, Harris G In vitro activity of meropenem and imipenem against mycobacteria: development of a daily antibiotic dosing schedule. Tubercle and Lung Disease 1992, 73: 134–136.

    Article  PubMed  Google Scholar 

  40. Lederer J, Warner W, Leggiadro RJ Clarithromycin treatment of posttraumaticMycobacterium fortuitum wound infection. Pediatric Infectious Disease Journal 1993, 12: 697–698.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Microbiology, University of Texas Health Center at Tyler, PO Box 2003, 75710, Tyler, Texas, USA

    R. J. Wallace Jr.

Authors
  1. R. J. Wallace Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wallace, R.J. Recent changes in taxonomy and disease manifestations of the rapidly growing mycobacteria. Eur. J. Clin. Microbiol. Infect. Dis. 13, 953–960 (1994). https://doi.org/10.1007/BF02111497

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02111497

Keywords

Search

Navigation